(19)
(11) EP 1 105 494 A2

(12)

(88) Date of publication A3:
22.06.2000

(43) Date of publication:
13.06.2001 Bulletin 2001/24

(21) Application number: 99944406.0

(22) Date of filing: 16.08.1999
(51) International Patent Classification (IPC)7C12N 15/31, C07K 14/40, A61K 31/70, A61K 38/16, C07K 16/14, G01N 33/50, C12Q 1/68
(86) International application number:
PCT/EP9905/991
(87) International publication number:
WO 0009/695 (24.02.2000 Gazette 2000/08)
(84) Designated Contracting States:
AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE
Designated Extension States:
AL LT LV MK RO SI

(30) Priority: 14.08.1998 GB 9817796
23.12.1998 EP 98310694

(71) Applicant: JANSSEN PHARMACEUTICA N.V.
2340 Beerse (BE)

(72) Inventors:
  • CONTRERAS, Roland Henri
    B-9000 Gent (BE)
  • NELISSEN, Bart
    B-2340 Beerse (BE)
  • DE BACKER, Marianne, Denise
    B-2340 Beerse (BE)
  • LUYTEN, Walter Herman Maria Louis
    B-2340 Beerse (BE)
  • VIAENE, Jasmine Elza
    B-9000 Gent (BE)
  • LOGGHE, Marc George
    B-9000 Gent (BE)

(74) Representative: De Corte, Filip Alois Julia 
Janssen Pharmaceutica N.V.Turnhoutseweg 30
2340 Beerse
2340 Beerse (BE)

   


(54) DRUG TARGETS IN CANDIDA ALBICANS